AnaptysBio, Inc. (ANAB)
NASDAQ·Healthcare·Biotechnology
$63.44
-4.05%
Mkt Cap $1.49B
Analyst Ratings
Buy
18
Hold
2
Sell
0
Price Target (26 analysts)
$73.71
Range $50.00 – $140.00
Implied Upside
+16.2%
Consensus $73.71 vs current $63.44
NASDAQ·Healthcare·Biotechnology
$63.44
-4.05%
Mkt Cap $1.49B
Buy
18
Hold
2
Sell
0
Price Target (26 analysts)
$73.71
Range $50.00 – $140.00
+16.2%
Consensus $73.71 vs current $63.44